,15(Z)-dienoate; RBF, Renal blood flow; GFR, glomerular filtration rate.
e) Cardiovascular
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INTRODUCTION

20-Hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid
produced by the cytochrome P450 (CYP) ω-hydroxylases including members of the CYP4A and 4F gene families (Capdevila et al., 1992) . This eicosanoid affects vascular and renal functions in a manner consistent with a potential involvement in the implementation of both pro-and antihypertensive mechanisms (Williams et al., 2010; Wu et al., 2014) .
Previous studies documented that arterial hypertension is associated with derangement in 20-HETE production at vascular and/or renal tubular sites in various experimental models.
For example, the development of hypertension in animals displaying augmentation of 20-HETE biosynthesis at vascular sites was attributed to one or more actions of this eicosanoid promoting increased reactivity to myogenic and neuro-hormonal stimuli (Miyata and Roman, 2005; Hoopes et al., 2015) , endothelial dysfunction (Wang et al., 2006; Singh et al., 2007; Cheng et al., 2008) , and/or upregulation of angiotensin converting enzyme (Sodhi et al., 2010; Garcia et al., 2015; Garcia et al., 2016) , all actions capable of bringing about vasoconstriction and blood pressure elevation. On the other hand, the salt-sensitive hypertension featured by transgenic mice overexpressing the human 20-HETE synthase CYP4A11 was attributed to enhanced retention of sodium resulting from 20-HETE-and angiotensin II-dependent upregulation of the sodium chloride co-transporter (NCC) (Savas et al., 2016) . Interestingly, salt-sensitive hypertension also was shown to develop in animals with depressed renal medullary synthesis of 20-HETE, which JPET #243618
interfere with 20-HETE actions is conditioned by the mix of the various vascular and renal blood pressure regulatory mechanisms involving this eicosanoid.
The present study was undertaken to examine this notion using Cyp4a14(-/-) male mice, which develop 20-HETE-dependent hypertension linked, sequentially, to upregulation of plasma androgen levels and enhanced renal expression of CYP4A12, the dominant 20-HETE synthase in mice (Holla et al., 2001; Wu et al., 2013; Gangadhariah et al., 2015) . First, we contrasted 
MATERIALS AND METHODS
Materials. 2,5,8,11,14,17-hexaoxanonadecan-19-yl 20-hydroxyicosa-6(Z) ,15(Z)-dienoate (20-SOLA) was synthesized as a PEG-conjugate of , an effective 20-HETE antagonist (Alonso-Galicia et al., 1999; Ding et al., 2013) . The 20-HETE antagonistic activity of 20-SOLA was examined by its ability to prevent 20-HETEmediated sensitization of the constrictor activity of phenylephrine in renal interlobar arteries as previously described (Zhang et al., 2001) . Briefly, cumulative concentration-response curves to phenylephrine (1x10 + 20-SOLA (1 µM). Phenylephrine elicited concentration-dependent increases of isometric tension as seen in Figure 1A . In vessels bathed in media containing 20-HETE, the concentration-dependent increase in tension produced by phenylephrine was shifted to the left revealing a major decrease in the EC50 of phenylephrine (Fig. 1B) . Co-addition of 20-SOLA prevented 20-HETE-mediated sensitization of phenylephrine-induced vasoconstriction (Fig. 1) .
FITC-inulin was obtained from Sigma-Aldrich (St. Louis, MO).
Animals. All experimental protocols were approved by the Institutional Animal Care and Use
Committee. The Cyp4a14(-/-) mouse model has been previously characterized (Holla et al.,
JPET #243618 intake, and urinary output were monitored daily. No differences were observed in food and water intake between Cyp4a14(-/-) and WT mice receiving 20-SOLA (data not shown). For blood pressure measurements, mice were acclimatized to the tail-cuff measurement for seven days prior to the start of experiments. In brief, mice were placed on an infrared heating pad for 7-10 minutes. Systolic blood pressure was recorded using the CODA non-invasive blood pressure system (Kent Scientific, Torrington CT) as previously described .
Urinary sodium concentration was determined by flame photometry and daily excretion rate was calculated. Renal blood flow (RBF) and glomerular filtration rate (GFR) were measured at the end of the 10-day experimental protocol as follows:
RBF was evaluated under anesthesia by using Laser Doppler flowmetry (Shi et al., 2007) . Briefly, a midline incision was performed to access the kidneys. Laser Doppler scanner was utilized to obtain a pseudo-colored scan of renal blood perfusion in live anesthetized mice.
A laparotomy was performed to expose the kidneys followed by assessment of cortical renal blood perfusion values using the laser-Doppler Perfusion Monitoring probes, image scanner, and accompanying software (PeriScan PIM II, PeriFlux system 5000, and LDPIwin version 2.6.1, respectively; PeriMed Instruments, PA). The correct positioning of laser-Doppler probes was verified after completion of each experiment.
GFR was measured by the FITC-Inulin clearance method (Rieg, 2013) . Briefly, FITCinulin (5% in 0.85% NaCl) was dialyzed against 0.85% NaCl for 24 h resulting in a ~2% solution that was used to establish the standard curve. The dialyzed FITC-inulin solution was sterile filtered and injected into the retro-orbital plexus (3.74 μl/g/body weight) during brief isoflurane anesthesia. At 3, 7, 10, 15, 35, 55 and 75 min after injection, blood was collected from the tail into a Na+ heparinized 70 μl capillary tube. After centrifugation, 10 μl of plasma was diluted 1:5 in 500 mM HEPES (pH 7.4) and fluorescence was determined on a 96-well plate using Synergy HT, Biotek with 485 nm excitation, and 538 nm emission. GFR was calculated using a twocompartment model of two-phase exponential decay (GraphPad Prism, San Diego, CA).
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Protocol 2: WT and Cyp4a14(-/-) mice undergoing pretreatment with either vehicle or 20-SOLA (10 mg/kg per day) for 72 hours were placed in metabolic cages for urine collection before and 4 hours after IP injection of isotonic saline (10% V/W). The amount of sodium excreted and the ratio of injected versus excreted sodium were assessed (Trott et al., 2014) .
Statistical Analysis. Data are expressed as mean ± SEM. Significance of difference in mean values was determined by using two-tailed t test for comparison between two groups or oneway ANOVA for multiple groups comparisons, followed by the Tukey-Kramer post hoc test.
P<0.05 was considered to be significant.
This article has not been copyedited and formatted. The final version may differ from this version. 
RESULTS
20-SOLA Normalizes Blood Pressure in Cyp4a14(-/-) Male Hypertensive Mice
The Cyp4a14(-/-) mouse is a model of androgen-driven male-specific 20-HETEdependent hypertension; Cyp4a14(-/-) male mice are hypertensive whereas corresponding females are normotensive (Holla et al., 2001; Wu et al., 2013) . As previously reported, administration of the 20-HETE antagonist 20-HEDE or 20-SOLA normalizes blood pressure in the male Cyp4a14(-/-) mice without affecting renal or vascular levels of 20-HETE Gangadhariah et al., 2015) . As seen in Figure 2 , administration of 20-SOLA (10mg/kg/day) in the drinking water to Cyp4a14(-/-) male mice significantly reduced systolic blood pressure within 4 days of the onset of treatment, and normalized the blood pressure after 10 days of treatment. In contrast, the same treatment had no effect on systolic blood pressure in age-matched WT mice (Figure 2 ).
Impaired renal hemodynamic function is corrected by treatment with 20-SOLA in
Cyp4a14(-/-) mice
We contrasted male WT and Cyp4a14(-/-) mice treated with vehicle or 20-SOLA in terms of renal blood perfusion and GFR. As seen in Figure 3A , renal blood perfusion in hypertensive Cyp4a14(-/-) mice was significantly lower compared to WT controls. Treatment with 20-SOLA for 10 days did not affect renal perfusion in WT controls but increased renal perfusion in the hypertensive Cyp4a14(-/-) mice to the level observed in the WT controls ( Figure 3A) . GFR of to levels similar to that of WT mice ( Figure 3B ). Hence, 20-HETE appears to be a critical determinant not only of the hypertension featured by Cyp4a14(-/-) male mice but also of the JPET #243618 accompanying alterations in renal hemodynamics, viz., reduction in renal blood perfusion and GFR.
20-SOLA treatment increases urinary sodium excretion in male Cyp4a14(-/-) mice
Urinary volume of 7x24 h collections over 10 days was significantly lower in Cyp4a14 (-/-) mice when compared to corresponding WT mice (55.90±1.89 vs 60.29±3.14 µl/g BW/day, n=7, normotensive mice. The 20-HETE antagonist had no effect on sodium excretion or urine volume in normotensive mice but in hypertensive Cyp4a14(-/-) mice it caused slight elevation of urine volume and a robust increase of urinary sodium excretion. Since the natriuretic effect of 20-SOLA in Cyp4a14(-/-) hypertensive mice precedes by two days the onset of blood pressure reduction, it is conceivably that the enhanced sodium loss prompted by the 20-HETE antagonist is a primary contributor to the slightly delayed hypotensive effect, presumably via a mechanism involving reduction of extracellular fluid volume with attendant reduction of cardiac output (Williams et al., 2010) . This interpretation is not necessarily incongruent with the established concept that urinary sodium excretion is negatively affected by an associated reduction of blood pressure (Reckelhoff et al., 1998) . Indeed, in our study, the natriuretic effect of 20-SOLA in The notion that over production of 20-HETE-contributes to excessive renal conservation of sodium in Cyp4a14(-/-) hypertensive mice, fits well with our current findings confirming that these animals are impaired in their ability to increase urinary sodium excretion after an acute saline load (Fidelis et al., 2010) . Upregulation of renal 20-HETE synthesis, along with increased proximal tubule volume reabsorption and NHE3 protein abundance in kidney brush border membranes, also has been documented in rats treated with dihydrotestosterone (DHT) (Quigley, 2008) which increases blood pressure via mechanisms supported by 20-HETE and angiotensin II (Quan et al., 2004; Yanes et al., 2009) , that foster vasoconstriction and sodium conservation.
However, the concept that 20-HETE-driven sodium reabsorption in animals with androgendependent hypertension relies on upregulation of proximal tubule NHE3 expression is missing critical confirmatory evidence. In this regard, Quigley and associates have reported that rabbit proximal tubule volume transport is enhanced following pharmacological inhibition of 20-HETE synthesis, a finding which is reversed by acute exposure to exogenous 20-HETE (Quigley et al., 2000) . Hence, these observations argue strongly against the notion that endogenous 20-HETE fosters direct activation of renal NHE3. On the other hand, it would be premature to exclude from consideration a more complex mechanism for engagement of 20-HETE in promotion of sodium conservation, viz., a mechanism which includes an early step whereby 20-HETE of tubular origin stimulates the expression of components of the renin-angiotensin system intrinsic to renal tubular structures, ACE and/or angiotensinogen, with attendant elevation of angiotensin levels which, in turn, augment sodium reabsorption via activation of NHE3 and/or NCC (Dos Santos et al., 2004; Sodhi et al., 2010; Cheng et al., 2012; Savas et al., 2016) . Experimental support for this concept includes reports documenting that 20-HETE-dependent induction of ACE leads to elevation of angiotensin II tissue levels (Sodhi et al., 2010; Cheng et al., 2012) , that NHE3 is subject to stimulatory regulation by angiotensin II (McDonough, 2010) , and that hypertension in transgenic mice overexpressing the human CYP4A11 relies on excessive sodium retention dependent on 20-HETE-and angiotensin II-dependent upregulation of NCC (Savas et al., 2016) . Further experiments are required to examine the activity of NHE3 in proximal tubule and NCC in distal convoluted tubule in Cyp4a14(-/-) mice.
In summary, this study underscores the significance of excessive 20-HETE production to the hypertensive phenotype displayed by Cyp4a14(-/-) male mice, which is associated with diminished renal blood perfusion and GFR and impaired ability to excrete an acute sodium load. 
